Development and validation of a lung cancer risk prediction model
Principal Investigator
Name
Martin Tammemagi
Degrees
DVM; MSc; PhD
Institution
Henry Ford Health System
Position Title
Professor of Epidemiology
About this CDAS Project
Study
NLST
(Learn more about this study)
Project ID
201110-0018
Initial CDAS Request Approval
Oct 25, 2011
Title
Development and validation of a lung cancer risk prediction model
Summary
The general purpose of this study is to attempt to validate and further enhance a lung cancer risk prediction model developed in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial data. The PLCO model is describe in the following paper: Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. Journal of the National Cancer Institute 2011;103(13):1058-68.
Collaborators
Gerard Silvestri
Related Publications
-
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.
Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD
PLoS Med. 2014 Dec; Volume 11 (Issue 12): Pages e1001764 PUBMED -
Selection criteria for lung-cancer screening.
Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, Chaturvedi AK, Silvestri GA, Riley TL, Commins J, Berg CD
N. Engl. J. Med. 2013 Feb; Volume 368 (Issue 8): Pages 728-36 PUBMED